Related Experiment Video
Updated: May 1, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
34.6K
[Diabetes mellitus--risk factor for atrial fibrillation. Potential therapeutic implications]
1Deutsche Herzstiftung, Vogtstr. 50, 60322, Frankfurt am Main, Deutschland, tm@prof-meinertz.com.
Herz
|April 5, 2014
Summary
Diabetes mellitus type 2 significantly increases the risk of atrial fibrillation, doubling the likelihood of this heart condition. This combination elevates risks for cardiovascular events and mortality, highlighting the need for targeted therapies.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Context:
- The link between diabetes mellitus type 2 and atrial fibrillation remains debated, with prior research yielding inconsistent findings.
- Recent large-scale prospective studies increasingly indicate a significant positive association between these two conditions.
Purpose:
- To investigate the relationship between diabetes mellitus type 2 and the risk of developing atrial fibrillation.
- To clarify the impact of this comorbidity on cardiovascular outcomes and mortality.
Summary:
- Diabetes mellitus type 2 is independently associated with at least a two-fold increased risk of atrial fibrillation after adjusting for confounding factors.
- The coexistence of atrial fibrillation and diabetes mellitus type 2 substantially elevates the risk of mortality, stroke, and heart failure.
Impact:
- Patients with both conditions may experience greater benefits from aggressive glycemic control, anticoagulation, and antihypertensive treatments.
- Identifying atrial fibrillation in diabetic patients is crucial for risk stratification and optimizing management strategies to improve patient outcomes.
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
1.2K
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.2K
01:24Drug Toxicity: Risk factors
229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
01:30Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
2.3K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.3K
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28